Genesis MedTech Introduces China’s 1st Domestic Brand of NPMA-approved Antibacterial Sutures

Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China’s National Medical Products Administration (NMPA) for market release.

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and gram-negative bacteria. These advanced sutures effectively inhibit the growth of Staphylococcus aureus, Staphylococcus epidermidis, methicillin- resistant Staphylococcus aureus (MRSA), methicillin-Resistant Staphylococcus epidermidis (MRSE), thereby significantly reducing the risk of surgical site infections.

Surgical site infections are one of the most frequently reported types of hospital-acquired infection and are associated with substantial clinical and economic burdens. Authoritative institutions, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), have issued guidelines for the prevention of surgical site infection1 and unequivocally affirmed the effectiveness of antimicrobial agent-coated sutures in lowering the risk of surgical site infections across diverse surgical procedures.

Alongside the highly anticipated absorbable antibacterial sutures, Genesis MedTech continues to expand its suture product lines with comprehensive offerings. The company achieved a significant milestone in September 2022 with the NMPA approval of its barbed sutures. Furthermore, its barbed absorbable sutures with black needle, non-absorbable surgical polypropylene sutures, and controlled-release needle sutures have been widely used in thousands of hospitals nationwide. These outstanding products exemplify Genesis MedTech’s dedication to enhancing surgical care and meeting diverse needs of healthcare professionals and patients alike.

Warren Wang, Chairman and CEO of Genesis MedTech Group, expressed his excitement stating, “We are thrilled to achieve this significant milestone as the first domestic brand in China to develop antibacterial sutures. This pioneering innovation has immense potential to benefit numerous patients. Genesis will introduce more innovative products as part of the company’s roadmap, as we continue our mission to make quality healthcare more accessible for patients worldwide.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy